Walgreens stock tumbles on report that private equity deal is unlikely
Shares of Walgreens Boots Alliance tumbled today following a CNBC report that the Deerfield-based pharmacy chain was unlikely to sell itself to a private-equity firm. CNBC’s David Faber reported on air this morning that sources say the possible deal in which Walgreens would sell itself to New York-based Sycamore Partners is “mostly dead.”
Walgreens private equity sale 'mostly dead': Report
Sources told CNBC's David Faber that a private equity firm's prospective deal to acquire Walgreens Boots Alliance is
Walgreens Stock Tumbles. Report Says Private-Equity Bid for Pharmacy Chain ‘Mostly Dead.’
The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be finalized early this year.
Walgreens Stock Falls on Concerns Potential Buyout Deal is ‘Dead’
Shares of Walgreens Boots Alliance tumbled after a report that the pharmacy chain’s talks to sell itself to a private-equity firm are unlikely to result in a deal. CNBC’s David Faber said on air his s
Walgreens stock tumbles on deal concerns
Shares of Walgreens (NASDAQ: WBA) fell sharply by 9% following reports that a potential acquisition by private equity firm Sycamore Partners may not materialize. CNBC's David Faber indicated that the deal,
Walgreens drops on report that Sycamore potential deal is likely dead
Walgreens Boots (NASDAQ:WBA) fell 6.6% on a report that a potential takeover by private equity from Sycamore Partners is likely not going to happen. "It's mostly dead," CNBC's David Faber said on Monday on the business network.
Drug Store News2d
Walgreens buyout talks reportedly unlikely to culminate in a deal
A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York ...
Becker's ASC1d
Walgreen's private equity sale likely abandoned: 5 things ASCs need to know
Walgreens Boots Alliance's prospective sale to a private equity firm is " mostly dead ," sources told CNBC's David Faber, according to a Jan. 27 report from The Wall Street Journal. Here are five ...
kffhealthnews2d
Walgreens Unlikely To Sell To Private Equity Firm Sycamore Partners
Pharmacy chain Walgreens has been struggling for over a year and has been in talks to sell to Sycamore Partners, a deal that is now "mostly dead." Meanwhile, some independent pharmacies are opting to ...
Hold Rating Maintained for Walgreens Boots Alliance Amid Acquisition Uncertainty and Legal Challenges
Analyst Michael Cherny of Leerink Partners reiterated a Hold rating on Walgreens Boots Alliance (WBA – Research Report), retaining the price ...
Modern Healthcare23h
Advocate Health closing Walgreens clinics in two states
Advocate Health is shuttering 55 clinics inside Walgreens stores in Illinois and Wisconsin, effective Feb. 6.
Forbes19d
Walgreens Pharmacy Strength And CEO Comments Toss Cold Water On Private Equity Deal
Walgreens continues to discount that report ... drive long-term value indicate that the rumored sale to PE firm Sycamore Partners is less likely." Mizuho Securities USA analyst Ann Hynes, too ...
Walgreens Boots slides after CNBC’s Faber calls Sycamore deal ‘mostly dead’
Shares of Walgreens Boots Alliance (WBA) are down about 3% to $11.49 in early trading after CNBC’s David Faber said on-air that his sources ...